Bernstein Liebhard LLP announced that a securities class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of a class of purchasers of Vitamin Shoppe, Inc. common stock between May 8, 2012 and February 25, 2013. The complaint charges Vitamin Shoppe and certain of its officers and directors with violations of the Securities Exchange Act of 1934. The complaint alleges that during the class period, defendants issued materially false and misleading statements regarding the company's operations, business trends and same-store sales trends. Specifically, defendants failed to disclose that: Vitamin Shoppe's business was then being negatively impacted by competition from on-line retailers which were significantly reducing prices on popular supplements; GNC's new discount program was negatively impacting the company's sales growth; and the company was experiencing declining same-store sales trends. As a result of defendants' false and misleading statements, Vitamin Shoppe common stock traded at artificially inflated prices, enabling Company insiders to sell more than $30 million of their personally held Vitamin Shoppe common stock at inflated prices during the class period. Then, on February 25, 2013, according to the complaint, after guiding toward strong fiscal 2012 sales and profits during the class period, Vitamin Shoppe announced lackluster financial results for the company's fiscal and fourth quarter 2012. In response, the price of the company's stock fell $11.86 per share, or more than 18.76% that day. Plaintiffs seek to recover damages on behalf of all class members who invested in Vitamin Shoppe stock during the class period.

Robbins Geller Rudman & Dowd LLP announced that a class action has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Vitamin Shoppe, Inc. common stock during the period between May 8, 2012 and February 25, 2013. The complaint alleges that during the Class Period, defendants issued materially false and misleading statements regarding the Company's operations, business trends and same-store sales trends. Specifically, defendants failed to disclose that: (i) Vitamin Shoppe's business was then being negatively impacted by competition from on-line retailers which were significantly reducing prices on popular supplements; (ii) GNC's new discount program was negatively impacting the Company's sales growth; and (iii) the Company was experiencing declining same-store sales trends. As a result of defendants' false and misleading statements, Vitamin Shoppe common stock traded at artificially inflated prices, enabling Company insiders to sell more than $30 million of their personally held Vitamin Shoppe common stock at inflated prices during the Class Period. Then, on February 25, 2013, according to the complaint, after guiding toward strong fiscal 2012 sales and profits during the Class Period, Vitamin Shoppe announced lackluster financial results for the Company's fiscal and fourth quarter 2012. In response, the price of the Company's stock fell $11.86 per share, or more than 18.76% that day.

Vitamin Shoppe, Inc. reported unaudited consolidated earnings results for the first quarter ended March 30, 2013. For the quarter, the company reported net sales increased 12.5% to $279.1 million compared to $248.1 million in the same period of the prior year. Sales growth in the quarter was driven by: 1) a 4.5% increase in comparable sales, 2) growth from new stores, 3) the contribution from Super Supplements retail stores of $9.6 million, and, 4) a 16.1% increase in ecommerce sales. Income from operations in fiscal first quarter 2013 was $34.7 million compared to $30.4 million in fiscal first quarter 2012. As a percentage of net sales, income from operations was 12.4% for the fiscal 2013 first quarter. Income before provision for income taxes was $34.58 million compared to $30.24 million last year. Net income was $20.8 million or $0.68 per diluted share compared with $18.3 million or $0.61 per diluted share for fiscal first quarter 2012. Capital expenditures were $11.84 million compared to $5.89 million last year. Capital expenditures were used primarily for the new distribution center, build-out of new stores, improvements to existing stores, as well as computer equipment related to those stores. Adjusted net income in fiscal first quarter 2013 was $22.0 million. Fiscal first quarter 2013 diluted EPS, was $0.72 excluding transaction and integration costs. For the current year, the company expects to open approximately 50 new stores. For the current year, the company expects low to mid single digit comparable store sales growth for the year; Capital expenditures of approximately $45 to $50 million, which includes capital for the new distribution center; Depreciation & amortization of approximately $28 million which includes the additional depreciation from the Super Supplements acquisition; and super Supplements acquisition is expected to be dilutive to earnings per share by approximately $0.03, which includes transaction and integration costs.